Amgen

www.amgen.com

Symbol: AMGN

Currently trading at: 53.64p DOWN 2.70

Amgen Inc, a Fortune 500 company, discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realise the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient.

Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses.

Amgen's European headquarters for clinical research is in the Cambridge Science Park, where around 300 people work.

Staff

Contact details

Articles relating to Amgen

News briefs: AVEVA wins Royal Navy aircraft carrier work

Briefs: Quotient buys mass spectrometers; Amgen, Cambridge Uni launch Scholars program

Subscribe

 

Corporate profiles

 • ARM Holdings

Mike Muller Chief Technology Officer & Director

ARM Holdings plc is the world's leading semiconductor intellectual property (IP) supplier and as such is at the heart of the development of digital electronic products. The continuing evolution of electronic devices becoming more digital and more intelligent has escalated to the extent that the use of

[ARM Holdings's profile]

Top20 Index

Currently: 71.78

Create Publisher Site
This Publisher Website ( slot3.siliconfenbusiness.com ) does not exist in Direct-Link-Ads.com. Please create it now.